Melanoma/Skin Cancer Program
A Nationally Recognized Leader in Skin Cancer Care, Management and Investigation
The Melanoma and Skin Cancer Program at Beth Israel Deaconess Medical Center provides leading edge care for patients with the many types of skin cancer. The majority of patients treated by our team are those with melanoma and other advanced skin cancers, including advanced basal cell and squamous cell carcinomas.
Early-stage skin cancer is generally treated by the Department of Dermatology at BIDMC.
With our multidisciplinary team approach, we thoroughly investigate the diagnosis and staging of your cancer to determine the best course of treatment. Members of our team include medical, radiation and surgical oncologists, as well as pathologists, dermatologists, radiologists, nurse practitioners and nurse specialists who work together to provide a coordinated evaluation and treatment plan.
Cancerous skin lesions may be removed surgically, and you may receive chemotherapy, radiation therapy and/or biologic therapy. Based on our findings of the type and stage of cancer, we develop the best personalized plan of care for you.
In addition to a comprehensive treatment plan, you may be invited to participate in a clinical trial, which investigates new and potentially better treatment options to treat your type of cancer. Your participation is voluntary and optional.
The areas where our specialists are working to improve patient care and personalized treatment plans include:
- Melanoma prevention
- Genetics of melanoma in high-risk families
- Adjuvant therapy in patients with high-risk melanomas
- Cytokine and immunotherapy
- Assessing and manipulating tumor-induced immune suppression
- Molecularly targeted therapies
- Identifiying factors associated with disease progression or predictive of response to therapy